炎症组NLRP3与肝纤维化之间的相关性进展
Meihua Sun1, Yanqing Zhang1, Anbing Guo2
1School of Clinical Medicine, Weifang Medical University, Weifang, Shandong, China.
Journal of clinical and translational hepatology
|February 12, 2024
概括
类似NOD的受体蛋白3 (NLRP3) 炎症酶驱动肝纤维化进展. 准NLRP3及其通路为治疗慢性肝病提供了潜在的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 肝病学 肝病学是一种肝病学.
- 分子生物学分子生物学
背景情况:
- 肝纤维化是慢性肝病中的一个动态过程,需要对有效治疗的机制理解.
- 类似NOD的受体蛋白3 (NLRP3) 炎症体与先天性免疫和炎症性疾病的发病有关.
- 激活NLRP3是发展各种肝病的关键因素,包括病毒性,酒精性,非酒精性和自身免疫性肝病.
研究的目的:
- 阐明NLRP3炎症酶和相关分子在肝纤维化发展中的作用.
- 审查在肝病中控制NLRP3激活的信号通路.
- 根据NLRP3炎症酶调制,确定肝纤维化的潜在治疗点.
主要方法:
- 文献综述侧重于肝纤维化中的NLRP3炎症酶激活.
- 对参与NLRP3介导的肝损伤的信号通路的分析.
- 确定下游效应和治疗目标.
主要成果:
- 在各种病因方面,NLRP3炎症酶激活是肝纤维化病变的组成部分.
- 特定的信号级联调解NLRP3在肝脏中的亲纤维效应.
- NLRP3及其组件代表了抗纤维菌疗法的有希望的目标.
结论:
- 了解NLRP3炎症酶机制对于开发肝纤维化的新疗法至关重要.
- 针对NLRP3激活通路具有逆转或停止肝纤维化进展的治疗潜力.
- 对NLRP3向干预措施的进一步研究对于治疗慢性肝病是有必要的.
相关概念视频
01:23Cirrhosis I: Introduction
28
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
28
01:24Cirrhosis II: Pathophysiology
42
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
42